Global Leader in Drug Safety Intelligence

With over 50 years of experience, UMC is recognized as a pioneer in pharmacovigilance and a trusted partner for enhancing medicine safety globally. Their products and services, such as VigiBase and WHODrug, enable stakeholders across the pharmaceutical value chain to make informed decisions for the benefit of patients. UMC also provides guidance to countries on implementing robust systems for adverse event reporting and signal detection. , Uppsala Monitoring Centre (UMC) is an independent research organization that collects and analyzes pharmaceutical data from countries worldwide to ensure proper standards are upheld for patient safety. Located in Sweden, UMC operates the WHO Programme for International Drug Monitoring and manages VigiBase, the WHO's global database of reported drug side effects.

With over 50 years of experience, UMC is recognized as a pioneer in pharmacovigilance and a trusted partner for enhancing medicine safety globally. Their products and services, such as VigiBase and WHODrug, enable stakeholders across the pharmaceutical value chain to make informed decisions for the benefit of patients. UMC also provides guidance to countries on implementing robust systems for adverse event reporting and signal detection.